WELCOME TO SENTINEL PLUS

This medical education website has been funded by AstraZeneca and co-developed with Hull University Teaching Hospitals NHS Trust. This website is intended for UK healthcare professionals only.

I AM NOT A HEALTHCARE PROFESSIONAL

THIS NON-PROMOTIONAL WEBSITE IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY

Logo
☰
  • HOME
  • WHY SENTINEL MATTERS
    • › THE SENTINEL PLUS STORY
    • › PUBLICATIONS AND POSTERS
  • SENTINEL PLUS TOOLKIT
    • ›HEALTHCARE PROFESSIONAL EDUCATION
    • ›GOLD STANDARD PRESCRIBING PRACTICES
    • ›TARGETED ASTHMA REVIEWS
    • ›PATIENT SUPPORT AND EDUCATION
    • ›REAL TIME DATA MONITORING
  • SENTINEL TEAM
  • CONTACT

HEALTHCARE
PROFESSIONAL
EDUCATION

This pillar contains SENTINEL Plus healthcare professional education resources and provides the foundation for implementing the wider toolkit.

To support meaningful and sustained change, this education should be delivered across the full primary care team, including clinicians, pharmacists, nursing staff, and wider practice colleagues involved in asthma management and prescribing. You may consider building it into inductions for new staff and/or introducing this as annual mandatory training.

ANTI-INFLAMMATORY
ASTHMA MANAGEMENT

 

This video:

  • introduces the principles of anti-inflammatory based asthma management
  • outlines the concepts of as needed anti-inflammatory reliever (AIR) and maintenance and reliever therapy (MART) 
  • discusses how this approach aligns with the 2024 BTS/NICE/SIGN guidelines.

SELECTING THE MOST
APPROPRIATE INHALER DEVICE

 

This video:

  • explains why shared decision-making with patients when choosing and reviewing inhaler therapies is important
  • why a collaborative approach supports better adherence and can improve inhaler technique
  • discusses how choosing the right inhaler for your patient can increase the likelihood of sustained asthma control.

THE SENTINEL PLUS PROSPECTUS

The SENTINEL Plus prospectus provides an overview of the rationale behind SENTINEL and SENTINEL Plus, the impact of the original SENTINEL quality improvement project and the 5 pillars of implementation:

DOWNLOAD SENTINEL PLUS PROSPECTUS
RETURN TO TOOLKIT

GB-76216 | May 2026

SENTINEL Plus is developed with the aim of improving outcomes for asthma patients through identifying and addressing short-acting beta 2 agonist (SABA) over-reliance

SITE PAGES

  • Home
  • Why SENTINEL matters
  • SENTINEL Plus Toolkit
  • SENTINEL Team
  • Contact

LEGAL

  • Terms of use
  • Privacy Policy
  • Cookie Policy

GB-76210 | May 2026

2026 SENTINEL Plus

SENTINEL Plus is a quality improvement framework, providing educational resources. This non-promotional website is funded by AstraZeneca and co-developed with Hull York Medical School and Hull University Teaching Hospitals NHS Trust. Intended for UK Healthcare Professionals Only.